Global Health Data Exchange - Discover the World's Health Data

Luxembourg Cohort of Positive Patients for COVID-19: A Stratification Study to Predict Patient Prognosis 2020-2024, Month 12, 15 and 24 Long COVID Symptoms Aggregated Dataset

Nav

General Info
Original or alternative title 
Predi-COVID; M12, M15, and M24
Provider 
Luxembourg Institute of Health (LIH)
Microdata access: Request
Geography 
Luxembourg (LUX)
Coverage type 
Country
Time period covered 
05/2020 - 07/2024
Data type
Survey:
  • Individual
  • Longitudinal
Summary 

"The “Predi-COVID” cohort study aims to identify important risk factors and biomarkers associated with COVID-19 severity, long-term health consequences of the disease and viral escaping natural or induced COVID-19 immunity. The main objective of Predi-COVID is to identify clinical, epidemiological and omics characteristics associated with the severity of COVID-19, which will then be used to further stratify the study population into clusters of disease severity with similar pattern and disease course. The Predi-COVID study was approved by the Luxembourgish Ministry of Health and by the National Committee for Research Ethic on April 23rd, 2020 and has been registered on Clinicaltrials.gov (NCT04380987)"

Source: Predi-COVID

Keywords 
Anxiety, Breathing difficulty, COVID-19, Cognitive impairment, Cough, Fatigue, Long COVID, Loss of smell, Loss of taste, Pain, SF-12, Standardized assessment tools, Symptoms, Unipolar depressive disorders
GHDx Entry last modified on: Feb 25, 2025